NEW YORK, July 16 - Signature BioScience has acquired Cambridge Discovery Chemistry (CDC) from Millennium Pharmaceuticals, Signature BioScience said Monday. Financial details were not disclosed.

Millennium had acquired CDC, based in Richmond, Calif., as part of its acquisition of UK-based Cambridge Discovery Chemistry Limited, the parent company of CDC, in July 2000. Millennium will continue to operate Cambridge Discovery Chemistry Limited as a wholly-owned subsidiary. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.